Literature DB >> 21573890

Diffuse alveolar hemorrhage associated with lenalidomide.

Mizu Sakai1, Tetsuya Kubota2, Yoshio Kuwayama1, Takayuki Ikezoe1, Akihito Yokoyama1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21573890     DOI: 10.1007/s12185-011-0871-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

1.  Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.

Authors:  L G Corral; P A Haslett; G W Muller; R Chen; L M Wong; C J Ocampo; R T Patterson; D I Stirling; G Kaplan
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

Review 2.  Drug-induced lung disease.

Authors:  M Ozkan; R A Dweik; M Ahmad
Journal:  Cleve Clin J Med       Date:  2001-09       Impact factor: 2.321

3.  A case of lenalidomide-induced hypersensitivity pneumonitis.

Authors:  Erika Lerch; Sandor Györik; Jonas Feilchenfeldt; Luca Mazzucchelli; Franco Quadri
Journal:  Onkologie       Date:  2010-04-13

4.  Lenalidomide-induced interstitial lung disease.

Authors:  Yijia Chen; Porntip Kiatsimkul; Kenneth Nugent; Rishi Raj
Journal:  Pharmacotherapy       Date:  2010-03       Impact factor: 4.705

Review 5.  Diffuse alveolar hemorrhage.

Authors:  Harold R Collard; Marvin I Schwarz
Journal:  Clin Chest Med       Date:  2004-09       Impact factor: 2.878

6.  Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide.

Authors:  Aaron Thornburg; Rafat Abonour; Patricia Smith; Kenneth Knox; Homer L Twigg
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

7.  Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Authors:  Meletios Dimopoulos; Andrew Spencer; Michael Attal; H Miles Prince; Jean-Luc Harousseau; Anna Dmoszynska; Jesus San Miguel; Andrzej Hellmann; Thierry Facon; Robin Foà; Alessandro Corso; Zvenyslava Masliak; Marta Olesnyckyj; Zhinuan Yu; John Patin; Jerome B Zeldis; Robert D Knight
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

Review 8.  Drug-induced pulmonary disease.

Authors:  E C Rosenow; A H Limper
Journal:  Semin Respir Infect       Date:  1995-06

Review 9.  Pulmonary complications of novel antineoplastic agents for solid tumors.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Chest       Date:  2008-02       Impact factor: 9.410

Review 10.  Mechanism of action of lenalidomide in hematological malignancies.

Authors:  Venumadhav Kotla; Swati Goel; Sangeeta Nischal; Christoph Heuck; Kumar Vivek; Bhaskar Das; Amit Verma
Journal:  J Hematol Oncol       Date:  2009-08-12       Impact factor: 17.388

  10 in total
  4 in total

1.  Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide.

Authors:  Masaki Iino
Journal:  Int J Hematol       Date:  2011-12-27       Impact factor: 2.490

2.  Pulmonary alveolar hemorrhage possibly associated with lenalidomide use.

Authors:  Yasuo Oshima; Arinobu Tojo
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

3.  Lenalidomide-induced diffuse alveolar hemorrhage.

Authors:  S Saheer; Balamugesh Thangakunam; Devasahayam Jesudas Christopher; Biju George
Journal:  Lung India       Date:  2014-01

4.  Lenalidomide-induced eosinophilic pneumonia.

Authors:  Andrew Toma; Aaron P Rapoport; Allen Burke; Ashutosh Sachdeva
Journal:  Respirol Case Rep       Date:  2017-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.